Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005180 |
---|---|
Receipt number | R000006129 |
Scientific Title | phase II study of panitumumab with irinotecan as third-line treatment for advanced colorectal cancer patients |
Date of disclosure of the study information | 2011/03/03 |
Last modified on | 2016/03/04 10:36:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/03/03 14:04:02 | ||
2 | Update | 2016/03/04 10:34:01 | Email Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2016/03/04 10:36:22 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |